SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
31.70
09-五月-25 16:45:00
15 分钟延时
股票
+0.16
+0.51%
今日范围
31.22 - 32.22
ISIN
N/A
来源
NASDAQ
-
Supernus to Host First Quarter 2021 Financial Results Conference Call
27 4月 2021 17:44:01 条件 Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
02 4月 2021 16:58:32 条件 Nasdaq GlobeNewswire
-
Supernus to Present at Cowen Healthcare Conference
26 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
25 2月 2021 16:00:00 条件 Nasdaq GlobeNewswire
-
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
23 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
08 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference
06 1月 2021 17:29:08 条件 Nasdaq GlobeNewswire